
Eli Lilly sued the Health Resources and Services Administration (HRSA) for allegedly blocking the pharma giant's proposal to change the manner by which it offers discounts on medicines under a federal program.
Pharma companies use the 340B Drug Pricing Program to supply drugs at discounted prices to eligible healthcare organizations and covered entities serving low-income populations.